OAM botanical symposium
This article was originally published in The Tan Sheet
Executive Summary
FDA and the National Institutes of Health's Office of Alternative Medicine are cosponsoring "Symposium on Botanicals: A Role in U.S. Health Care?" which will take place Dec. 14-16 at the Omni Shoreham Hotel in Washington, D.C. The symposium will include sessions on how regulations affect the marketplace, how to improve the regulation of botanicals and ways of ensuring that botanicals will be of good quality. Speakers at the symposium will include individuals from the dietary supplement industry, the U.S. Pharmacopeia, law firms, NIH, and FDAers Mitchell Zeller, Michael Kennedy, and Robert Temple
|
FDA and the National Institutes of Health's Office of Alternative Medicine are cosponsoring "Symposium on Botanicals: A Role in U.S. Health Care?" which will take place Dec. 14-16 at the Omni Shoreham Hotel in Washington, D.C. The symposium will include sessions on how regulations affect the marketplace, how to improve the regulation of botanicals and ways of ensuring that botanicals will be of good quality. Speakers at the symposium will include individuals from the dietary supplement industry, the U.S. Pharmacopeia, law firms, NIH, and FDAers Mitchell Zeller, Michael Kennedy, and Robert Temple. |